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Summary
Hypoxic preconditioning (HP) is a rapid and reversible
proadaptive response to mild hypoxic exposure with
such a response protecting cells from subsequent
hypoxic or ischemic insult [1, 2]. HP mechanisms are
of great interest because of their therapeutic potential
and insight into metabolic adaptation and cell death.
HP has been widely demonstrated in the vertebrate
subphylumbut not in invertebrates [2]. Here, we report
that the nematode Caenorhabditis elegans has a po-
tent HP mechanism that protects the organism as
well as its neurons and myocytes from hypoxic injury.
The time course of C. elegans HP was consistent with
vertebrate-delayed HP, appearing 16 hr after precondi-
tioning and lasting at least 36 hr. The apoptosis path-
way has been proposed as either a trigger or target
of HP. Testing ofmutations in the canonicalC. elegans
apoptosis pathway showed that in general, genes in
this pathway are not required for HP. However, loss-
of-function mutations in ced-4, which encodes an
Apaf-1 homolog, completely blocked HP. RNAi silenc-
ing of ced-4 in adult animals immediately preceding
preconditioning blocked HP, indicating that CED-4 is
required in adults during or after preconditioning.
CED-4/Apaf-1 is essential for HP inC. elegans and acts
through a mechanism independent of the classical
apoptosis pathway.
Results and Discussion
All aerobic animals require oxygen for survival. However,
they and their cells vary dramatically in oxygen require-
ments and abilities to survive after hypoxia. Certain mam-
malian cells, most notably cardiac myocytes and neu-
rons, have the ability to alter their hypoxic sensitivities
after a sublethal ischemic or hypoxic incubation. This
adaptive phenomenon is called ischemic or hypoxic pre-
conditioning (HP) and has been demonstrated in a large
variety of mammalian cell types [1, 2]. Cellular protection
by HP occurs in two temporally distinct phases, early and
late. Hypoxic protection by early preconditioning occurs
within minutes, peaks in approximately an hour, and lasts
for approximately 4 hr. Protection by late preconditioning
does not become evident until 12–24 hr after the precon-
ditioning stimulus but can last several days. The mecha-
nisms of early and late preconditioning appear to be
*Correspondence: crowderm@morpheus.wustl.edudistinct with late preconditioning, but not early, requiring
new transcription and translation. In particular, the mech-
anisms of late preconditioning are poorly understood.
Because HP has not been reported in an invertebrate,
one outstanding question is whether this adaptive re-
sponse to hypoxia is restricted to vertebrates or is also
present in invertebrates, and if so, might the mechanism
require evolutionarily conserved components?
Hypoxic Preconditioning in C. elegans
The nematode Caenorhabditis elegans is sensitive to
hypoxic injury [3–5]. C. elegans neurons, myocytes, and
the whole animal are injured and killed by hypoxic expo-
sure [5], and genes have been identified that regulate
cellular and whole-animal hypoxic sensitivity [3–7]. We
tested whether C. elegans has an HP mechanism that
can protect from whole-animal death. Indeed, a 4 hr hy-
poxic exposure followed by 20 hr recovery resulted in
protection from a subsequent 20 hr hypoxic incubation.
After recovery from the hypoxic incubation, HP-treated
animals were not only alive but also moving relatively
normally compared to the paralyzed or dead no-HP con-
trols (Figures 1A and 1B). We performed the hypoxic
preconditioning incubation by transferring animals from
their normal growth conditions, normoxia at 20 on agar
plates seeded with bacteria, to liquid buffer in the hypoxia
chamber at 26. We tested whether the hypoxia was re-
sponsible for the preconditioning as opposed to higher
temperature or incubation in the liquid. Not higher tem-
perature, liquid, or their combination resulted in any
significant hypoxia protection against animal death,
whereas hypoxic incubation on agar plates resulted in
the same amount of protection, albeit more variable, as
liquid hypoxic incubations (Figure 1C). A 4 hr hypoxic
incubation at 25, a common temperature for culture of
C. elegans, also induced significant preconditioning
(Figure S1 in the Supplemental Data available online).
Thus, hypoxia at a more physiological temperature is still
capable of inducing a protective response. We also ex-
amined whether hypoxic preconditioning provided pro-
tection from thermal insults. C. elegans is killed by pro-
longed incubation at 37. We observed no protection by
HP from the lethality of a 37 incubation (Figure S2).
Thus, despite the 26 preconditioning temperature, cer-
tainly a cellular stress in its own right for C. elegans, our
results find no evidence for crosstolerance to hyperther-
mia. However, our data do not rule out the possibility of
a synergy between the stresses of higher temperature
and hypoxia resulting in preconditioning.
We next tested the onset and duration of HP protec-
tion. Significant protection from hypoxic injury was not
seen until the recovery time between the end of the pre-
conditioning incubation, and the hypoxic killing incuba-
tion was 8 hr. The protection lasted for up to 28 hr
(Figure 1D). The precision of determining the onset and
duration of HP was limited by the long 20 hr hypoxic kill-
ing incubation. Thus, sodium azide, a hypoxia mimetic
that kills with only a 1 hr incubation, was used instead.
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1955Figure 1. Hypoxic Preconditioning Protects
C. elegans from Lethal Hypoxic Insults
(A and B) Time-lapse images of (A) hypoxia
preconditioned versus (B) nonpreconditioned
adult worms after a 20 hr recovery from a
20 hr hypoxic incubation (pO2 < 0.3%). Note
well-moving preconditioned animals and im-
mobile nonpreconditioned animals without
tracks in the bacterial lawn.
(C) Preconditioning requires hypoxia, not just
higher temperature or buffer. Preconditioning
for 4 hr and then 20 hr recovery were varied
by normoxic or hypoxic, 20 or 26, in liquid
or on agar incubations as noted. Bars re-
present mean 6 SEM of three trials (>50
animals/trial). *p < 0.01 versus normoxic,
20, agar condition (two-tailed t test).
(D and E) Onset and duration of protection by
hypoxic preconditioning from hypoxic (D) or
azide (E) killing. After a 4 hr HP incubation,
animals were allowed to recover for varying
times in room air at 20 on agar prior to a 20
hr hypoxic or 1 hr 0.5M azide killing incuba-
tion. *p < 0.01 versus zero HP recovery time
(two-tailed t test). Data points represent
mean 6 SEM.
(F) Length of hypoxic incubation time re-
quired for producing HP. The length of the
hypoxic preconditioning at 26 in buffer was
varied and was followed 20 hr later by a
20 hr hypoxic killing incubation. *p < 0.01
versus no HP incubation (two-tailed t test).Protection by HP from azide-induced death was not ob-
served until 16 hr after preconditioning and remained for
at least 36 hr (Figure 1E). The protection by HP against
hypoxic and azide death and the lack of protection
against thermal insult indicate that the induced protec-
tive response is relatively specific for hypoxia or hypoxia
mimeticssuch as sodium azide. Finally, we measured the
duration of the hypoxic preconditioning incubation re-
quired for protection. Only longer incubations of 2 and
4 hr resulted in significant protection (Figure 1F), indicat-
ing that a strong hypoxic stimulus is required for HP in
C. elegans. The onset and duration are similar to that for
late preconditioning in mammalian tissue. No evidence
for early preconditioning was found, indicating that
C. elegans lacks the mechanism that was present in ver-
tebrate cells and that was necessary for early HP or, at
least, a mechanism sufficient to protect the whole animal
from death. Our results show thatC. eleganshas a mech-
anism for hypoxic preconditioning and that mechanisms
for HP extend beyond the vertebrate subphylum.
Hypoxic Preconditioning Prevents Necrotic,
Myocyte, and Neuronal Cell Death
Preconditioning has been studied most intensively in
mammalian cardiac myocytes and neurons, which areparticularly vulnerable to hypoxic injury. Thus, we asked
whether C. elegans myocytes and neurons were pro-
tected by HP. Previously, we have shown that hypoxia
produces characteristic pathological changes in both
myocytes and neurons [5]. C. elegans myocyte nuclei
become fragmented and are reduced in number after
hypoxia. Neuronal hypoxic injury inC. elegansmanifests
as severe axonal beading similar to what is observed
after traumatic spinal-cord injury. HP markedly reduced
both myocyte and neuronal pathology after hypoxia
(Figures 2A, 2B, 2D, and 2E). The results suggest that
C. elegansmyocytes and neurons are capable of mount-
ing a preconditioning adaptive response after hypoxia,
although a non-cell autonomous mechanism has not
been ruled out. We have also previously shown that hyp-
oxia induces a necrotic cell death in C. elegans. HP sig-
nificantly reduced necrotic cell death as well (Figures
2C–2F).
The Apaf-1 Homolog CED-4 Is Required for
HP by a Novel Mechanism
A number of mechanisms have been proposed for de-
layed preconditioning [2, 8]. Among these mechanisms,
the apoptosis pathway has repeatedly been implicated
in HP. Evidence for two sorts of roles of apoptosis has
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L1 larvae underwent no hypoxic incubation (Normoxia) or a 20 hr hypoxic incubation that was preceded by 4 hr HP (HP) or normoxic precondi-
tioning (No HP). After a 24 hr recovery, surviving animals were scored for cell pathological defects. Scale bars represent 20 mm.
(A and D) Muscle nuclear pathology reduced by HP. Muscle nuclei were visualized by nuclear-localized GFP driven by a muscle-specific pro-
moter, Pmyo-3. Hypoxia produces damaged myocytes seen as nuclear fragmentation (arrow) and nuclear loss (arrowhead) [5] that is reduced
by HP (*p < 0.01 versus ‘‘No HP,’’ mean 6 SEM, n = 29 animals [No HP] and 44 animals [HP]).
(B and E) Axonal pathology reduced by HP. Touch sensory neurons were visualized by GFP driven by a touch-neuron-specific promoter, Pmec-4.
Hypoxia produces axonal beading pathology (arrow) [5] that is reduced by HP (*p < 0.01 versus ‘‘No HP,’’ mean6 SEM, n = 124 axons [no HP] and
116 axons [HP]).
(C and F) Necrotic cell death reduced by HP. Hypoxia produces necrotic cell death (arrow) [5] that is reduced by HP (*p < 0.01 versus ‘‘No HP,’’
n = 29 animals [no HP] and 44 animals [HP]).been found. Numerous studies have found that HP can
reduce apoptotic death [8, 9]. However, these studies
do not generally address whether HP exclusively inhibits
apoptotic death as opposed to other mechanisms of
death such as necrotic cell death. The mechanism by
which HP might reduce apoptotic death is not well es-
tablished, but some evidence points to an increase in the
activity of the apoptosis-inhibiting protein Bcl-2 [10–12].
A second potential role of the apoptosis pathway is as
a trigger for hypoxic preconditioning. The evidence for
such a role is scant and is essentially hypothetical [2,
13]. Apoptotic cell death in C. elegans is mediated
through a well-studied core pathway [14]. The most
upstream component in the pathway is the BH3-only
domain protein EGL-1, which acts to inhibit the Bcl-2
homolog CED-9. CED-9 in turn sequesters the Apaf-1
homolog CED-4 on the mitochondrial surface. Upon dis-
inhibition, by EGL-1, CED-4 is released from CED-9 and
then multimerizes with the caspase CED-3, resulting
in active caspase [14]. Developmental programmed
somatic cell death and DNA-damage-induced germ cell
death are both controlled by the entire core pathway,whereas programmed germ cell death is controlled by
only CED-9, -4, and -3.
We utilized the extensive collection of core apoptosis
pathway mutants to test the requirements of each gene
product in HP. Two egl-1 (null) mutants exhibited a nor-
mal HP response similar to that of the wild-type strain N2
(Figures 3A, 3B, and 3F and Table S1). Notably, both
egl-1 (null) strains were mildly but significantly hypoxia
resistant. Indeed, all loss-of-function mutations in the
apoptosis pathway were similarly hypoxia resistant (Fig-
ure 3 and Table S1). This resistance could be derived
from a general block of apoptotic cell death induced
after hypoxia or could be due to the presence of addi-
tional cells, normally fated to die, that somehow confer
a mild protection from hypoxic injury. In any case, a block
of developmental programmed cell death by egl-1(lf)
does not alter HP. Likewise, neither ced-9(lf) nor ced-
9(gf) block protection by HP (Figures 3C–3F and Table
S1); thus, the C. elegans Bcl-2 homolog is not required
for HP. Given these results, we were surprised to find
that the canonical ced-4(lf) allele n1162 failed to show
any protection by HP (Figures 3D–3F and Table S1).
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1957Figure 3. The Apaf-1 Homolog CED-4 Is Re-
quired for HP
(A–E) Open symbols represent data for no-
HP-treated animals; closed symbols repre-
sent HP-treated animals. Data are paired by
trial with concurrent HP and ‘‘No HP’’ ani-
mals. (A) shows paired values for the wild-
type strain N2; the 26 paired trials that were
done as controls for all of the programmed
cell death pathway experiments are shown.
As shown in (B), egl-1 is not required for HP.
egl-1(n3330) and egl-1(n1084 n3082), both
null alleles, are significantly protected by
HP. (C) ced-9 is not required for HP. Neither
ced-9(n1950 gf) nor ced-9(lf) (full genotype:
unc-69(e587) ced-9(n1950gf n2161lf); ced-
3(n2433)) block HP. As shown in (D), ced-4 is
required for HP. n1162, n1894, and n2274
carry stop-codon mutations in the ced-4
gene and probably represent null alleles
[18]. The rescue strain has the genotype
ced-1(e1735);ced-4(n1162);unc-31(e928);nEx7
[unc-31(+);ced-4(+)]. As shown in (E), multiple
ced-3 mutations do not block HP. (F) shows
the summary of the effect of programmed-
cell-death-pathway mutants on HP. The ratio
of the percentage that are dead in HP to that
for ‘‘No HP’’ in each trial are shown, mean 6
SEM; dotted line indicates unity. *HP versus
‘‘No HP’’ significantly different by paired t
test, p < 0.05.Testing of three additional ced-4(lf) alleles, along with
rescue of HP protection by transformation of ced-
4(n1162) with wild-type ced-4, confirmed that ced-4 is
required for HP (Figures 3D–3F and Table S1). Notably,
the ced-4(n2273) mutant inconsistently failed to precon-
dition. The n2273 mutation alters a splice acceptor se-
quence and decreases the function of two alternatively
spliced CED-4 isoforms, CED-4S and CED-4L. CED-4S
promotes programmed cell death; CED-4L prevents
programmed cell death [15]. Because n2273 and all the
other ced-4 mutants reduce the activity of both CED-4S
and CED-4L, we cannot determine whether CED-4S,
CED-4L, or both are required for HP. However, the partial
reduction-of-function effect of n2273 might explain its
weak HP-blocking phenotype. CED-4 not only is known
to activate the CED-3 caspase [16] but also has been
shown to have CED-3 independent mechanisms for
mediating cell death [17]. Multiple ced-3(lf) mutants ex-
hibited normal protection by HP (Figures 3E–3F and Ta-
ble S1). Additionally, the block in HP byced-4(lf) does not
require ced-3 as shown by the HP-defective phenotype
of a ced-4(lf);ced-3(lf) double mutant (Figure 3F and
Table S1). Thus, CED-4 regulates HP through a CED-3
independent mechanism. Indeed, CED-4 must act to
control HP by some novel mechanism that does not re-
quire any of the other known core apoptosis genes.
We examined two general mechanistic explanations
for the requirement of CED-4 for HP. First, we consideredthe trivial possibility that ced-4 mutants might block HP
by slowing oxygen depletion during the preconditioning
incubation, perhaps by altering initial oxygen stores or
gas exchange. If so, one would expect the kinetics of
hypoxia-induced behavioral defects to differ between
ced-4 mutant and wild-type animals. However, the time
course of hypoxia-induced paralysis was indistinguish-
able between the wild-type strain and ced-4(n1162)
(Figure S3). Second, we asked whether CED-4 transcript
levels are induced or repressed by hypoxic precondi-
tioning. Hypoxic induction of CED-4 transcripts would
suggest the possibility that increases in CED-4 levels
might somehow promote hypoxic preconditioning.
Alternatively, repression of CED-4 transcripts would be
consistent with HP suppressing a CED-4-mediated
death. We observed a 4- to 5-fold induction in CED-4
transcript levels that peaked 8 hr after a 4 hr hypoxic in-
cubation and remained elevated up to 16 hr later (Fig-
ure S4). However, a 4 hr normoxic preconditioning incu-
bation produced a similar induction in CED-4 transcripts
(Figure S4). Thus, induction of CED-4 transcription might
be necessary for HP, but it clearly is not sufficient.
CED-4 Is Required during Adulthood prior to,
during, or after Preconditioning for HP
Finally, we asked when ced-4 is required for HP. In
particular, we wanted to know whether ced-4, as has
been shown for programmed cell death, acts primarily
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or whether it might act in adults during or after precon-
ditioning to permit activation of the HP mechanism.
We fed animals bacteria carrying a ced-4(RNAi) con-
struct or empty vector for three different time periods:
pos-Ctrl, from embryonic hatching until hypoxic injury;
pre-HP, 20 hr immediately preceding the HP hypoxic in-
cubation; and post-HP, 20 hr immediately after the HP
hypoxic incubation (Figure 4A). As expected animals
fed ced-4(RNAi) throughout development and adult-
hood were HP defective and significantly different from
empty-vector animals (Figure 4B). Pre-HP animals
were also HP defective; post-HP ced-4(RNAi) animals
however were not significantly different from vector con-
trols, although there was a trend toward blocking HP
(Figure 4B). Thus, CED-4 is required for HP during or af-
ter preconditioning, and the lack of normal developmen-
tal programmed cell death in ced-4(lf) is not responsible
for blockade of HP.
In summary, hypoxic preconditioning has previously
only been reported in vertebrate organisms. The results
reported here show that an invertebrate has a mecha-
nism for HP. This decidedly broadens the phylogenetic
scope of HP and offers a forward-genetically-tractable
model organism for the study of HP. The HP mechanism
in C. elegans requires the Apaf-1 homolog CED-4. CED-
4 acts to control HP by a novel mechanism distinct from
its classic role in programmed cell death. In particular,
release of CED-4 from mitochondrial tethering by CED-
9 and the subsequent activation of CED-3 caspase are
not essential to the HP mechanism. Our findings beg the
question, what is the pathway through which CED-4
acts? Identification of this pathway should provide novel
insights into metazoan adaptations to hypoxic injury.
Figure 4. CED-4 Is Required Postdevelopmentally for HP
(A) A timeline of the experimental protocol is drawn to scale. Animals
were exposed to ced-4(RNAi) or empty-vector control at the periods
indicated. ‘‘Emb’’ stands for embryo.
(B) Comparison of HP protection for ced-4(RNAi) versus vector.
*p < 0.05 compared to empty vector (paired t test); mean 6 SEM
of at least three independent trials, >50 animals per trial.Supplemental Data
Experimental Procedures, four figures, and one table are available
at http://www.current-biology.com/cgi/content/full/17/22/1954/
DC1/.
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